NMR experiments for the compounds were performed in acetone-d6 or MeOH-d4. NMR spectra were acquired on a Bruker Biospin (Billerica, MA) Avance 360 MHz instrument with a room-temperature probe or an Avance 500 MHz spectrometer equipped with a 5 mm Triple Resonance Inverse (TCI) 1H/13C/15N cryoprobe with inverse geometry (proton coils closest to the sample). The central acetone or MeOH solvent peaks were used as the internal reference (δC 29.8 and δH 2.04 ppm for acetone; δC 49.0 and δH 3.30 ppm for MeOH). Typical standard Bruker implementations of the traditional suite of one-dimensional (1D; 1H and 13C) and two-dimensional (2D) NMR experiments [multiplicity-edited 13C, Distortionless Enhancement by Polarization Transfer (DEPT-135), homonuclear COrrelation SpectroscopY (COSY), Heteronuclear Single-Quantum Coherence (HSQC), and Heteronuclear Multiple-Bond Correlation (HMBC)] were used to elucidate/validate the structures. A small exponential multiplication line-broadening value (0.1 Hz) and zero-filling to a processed spectrum size (SI) of 256 K datapoints were applied to see the clear splitting of A3, A5, and Aα peaks from the DDC moiety, as well as the glucoside 1′ peak.